EndoRel Biosciences is an early-stage startup with proprietary technology to enhance intracellular drug delivery. By combining our Endosome to Cytosol Delivery (ECD) technology with small molecule, antisense, or protein-based drugs, or complementary delivery technologies including nanoparticles, we provide our customers (partners and collaborators) with a powerful tool for creating the next generation of therapeutics supporting human health and well-being.
Company Details
- Employees
- 2
- Founded
- 2021
- Address
- 2828 S Corbett Ave, Portland,oregon 97201,united States
- Industry
- Biotechnology
- Website
- http://endorelbio.com
- HQ
- Portland, Oregon
Endorel Biosciences Questions
Endorel Biosciences's website is http://endorelbio.com
Endorel Biosciences's LinkedIn profile is https://www.linkedin.com/company/endorel-biosciences
Endorel Biosciences has
2 employees.
View email and phone details for 2
employees at Endorel Biosciences.
Endorel Biosciences's industry is
Biotechnology
Endorel Biosciences's top competitors are
Araceli Biosciences,
Therafluor Inc,
Agonox, Inc.,
Xbiologix,
Ethos Commercial Advisors,
Oregon Bioscience Incubator And Otradi,
Invivo Biosystems,
Promedix Inc - Precision Patient Monitoring,
Pdx Pharmaceuticals,
Trace Biosciences.
Endorel Biosciences's categories are Biotechnology
Endorel Biosciences's founding year is 2021
